1. Home
  2. COLL vs PAR Comparison

COLL vs PAR Comparison

Compare COLL & PAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$48.66

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$37.18

Market Cap

1.4B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLL
PAR
Founded
2002
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
COLL
PAR
Price
$48.66
$37.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$47.50
$64.00
AVG Volume (30 Days)
494.7K
490.8K
Earning Date
02-26-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.63
N/A
Revenue
$757,067,000.00
$440,451,000.00
Revenue This Year
$26.35
$30.40
Revenue Next Year
$3.67
$12.01
P/E Ratio
$29.06
N/A
Revenue Growth
26.34
39.88
52 Week Low
$23.23
$31.65
52 Week High
$50.79
$77.55

Technical Indicators

Market Signals
Indicator
COLL
PAR
Relative Strength Index (RSI) 58.37 54.13
Support Level $44.51 $34.10
Resistance Level $50.79 $36.84
Average True Range (ATR) 1.45 1.25
MACD -0.40 -0.10
Stochastic Oscillator 63.89 64.93

Price Performance

Historical Comparison
COLL
PAR

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

Share on Social Networks: